IP Verse

Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta Cyclodextrin - EP3391890

PATENT ANALYSIS

Patent Details

Grant Date
Aug 25, 2021
Company
MERCK SHARP & DOHME CORP.
Oppositions

AERA A/S

ETHYPHARM

FRESENIUS KABI DEUTSCHLAND GMBH

GENERICS (U.K.) LIMITED

More patents of Merck Sharp & Dohme Corp.

EP3283882

EP1841493

EP3265122

Want to monitor this patent?

Feel free to send us a message here and we will get back to you